Go to deals
Private Equity | Healthcare

Thyssen'sche Handelsgesellschaft has acquired h/p/cosmos sports & medical GmbH

Thyssen’sche Handelsgesellschaft mbH (THG), a German strategic holding company, has acquired a majority stake in h/p/cosmos sports & medical GmbH. Founder and former sole shareholder Franz Harrer, who built h/p/cosmos into a global leader in niche medical and sports diagnostics equipment, remains invested as a minority partner. THG will support the company’s international growth and innovation plans, while the existing management team continues to run the business.

THG is a traditional German family office with a long-term investment approach focused on value preservation and sustainable growth.

h/p/cosmos is a leading German manufacturer of high-performance treadmill systems and related technologies for diagnostics, rehabilitation and elite sports. Founded in 1988 and headquartered in Traunstein, the company generates around US$20 million (€17 million) in annual revenue, exports approximately 80 percent of its products and serves customers in more than 90 countries worldwide. Its portfolio includes advanced treadmills, ergometers, gait trainers and integrated systems for ergometry, rehabilitation, cardiopulmonary and performance diagnostics, biomechanics and sports science. As a technology pioneer, h/p/cosmos has significantly shaped the global development of treadmill systems through innovations such as the Virtual Split-Belt, perturbation functions, the MDR-certified gaitway 3d treadmill and the patented Robowalk gait trainer.

Oaklins’ team in Germany acted as the exclusive buy-side advisor to THG in the acquisition of h/p/cosmos.

Parties

Talk to the deal team

Jan P. Hatje

Managing Partner
Hamburg, Germany
Oaklins Germany

Stephan Gröger

Senior Associate
Hamburg, Germany
Oaklins Germany

Jan-Niklas Maciolek

Associate
Hamburg, Germany
Oaklins Germany

Related deals

Medicija has acquired Saulės Šeimos Medicinos Centras
Healthcare

Medicija has acquired Saulės Šeimos Medicinos Centras

Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.

Learn more
Quimpharma has completed the divestiture of a product portfolio to Megalabs
Healthcare

Quimpharma has completed the divestiture of a product portfolio to Megalabs

Quimpharma has completed the divestiture of a product portfolio to Megalabs México.

Learn more
IXICO has completed a fundraising
Healthcare

IXICO has completed a fundraising

IXICO plc, a specialist in AI-driven neuroimaging analytics, has completed a US$13.5 million gross capital raise. The funds will be used to support the company’s tech bio strategy, which will see IXICO partner its platform to maximize its potential.

Learn more